Paul Hudson is CEO of the French pharmaceutical company Sanofi which is currently partnering on the development of two potential vaccines for COVID-19. Hudson took over as Sanofi’s CEO last year, and is confident the 100-year-old vaccine company is well-positioned to make and distribute a vaccine that is safe, accessible, and affordable. Hudson is encouraged by the collaboration he has seen within the pharmaceutical industry to combat the virus, and believes continued cooperation post-pandemic could lead to future medical breakthroughs. Join Washington Post columnist David Ignatius for a one-on-one conversation with Hudson on Tuesday, Nov. 10 at 11:30 a.m. ET. This is the first installment of a special two-part series with the CEOs leading the global pursuit of a treatment and vaccine for COVID-19. From safety and science, to innovation and inclusion, to collaborating for the common good, we will hear the latest developments on current clinical trials and the challenges of chasing a pandemic.